Lepu Biopharma Co (HKSE:02157) Scaled Net Operating Assets : 0.45 (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Lepu Biopharma Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Lepu Biopharma Co's operating assets for the quarter that ended in Jun. 2024 was HK$2,006.4 Mil. Lepu Biopharma Co's operating liabilities for the quarter that ended in Jun. 2024 was HK$822.6 Mil. Lepu Biopharma Co's Total Assets for the quarter that ended in Dec. 2023 was HK$2,607.9 Mil. Therefore, Lepu Biopharma Co's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.45.

Lepu Biopharma Co Scaled Net Operating Assets Historical Data

The historical data trend for Lepu Biopharma Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lepu Biopharma Co Scaled Net Operating Assets Chart

Lepu Biopharma Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.13

0.66

0.42

0.40

0.44

Lepu Biopharma Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial				0.39	0.33	0.37	0.48	0.45

Competitive Comparison of Lepu Biopharma Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Lepu Biopharma Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lepu Biopharma Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lepu Biopharma Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Lepu Biopharma Co's Scaled Net Operating Assets falls into.

Lepu Biopharma Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Lepu Biopharma Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(2072.343	-	819.004)	/	2824.364
=	0.44

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2607.904	-	535.561
=	2072.343

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1635.862	-	310.834	-	506.024
=	819.004

Lepu Biopharma Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(2006.398	-	822.603)	/	2607.904
=	0.45

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2627.852	-	621.454
=	2006.398

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1656.799	-	267.845	-	566.351
=	822.603

Lepu Biopharma Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Lepu Biopharma Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Lepu Biopharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lepu Biopharma Co Ltd (HKSE:02157) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 651, Lianheng Road, Minhang District, Shanghai, CHN, 201612

Website

https://www.lepubiopharma.com

Lepu Biopharma Co Ltd is a biopharmaceutical company focusing on oncology therapeutics and has one operating segment. The Group is principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The majority operating entity of the Group is domiciled in the PRC. The company has established an integrated end-to-end platform across drug discovery, clinical development, CMC, and GMP-compliant manufacturing, encompassing all critical functions of the biopharmaceutical value chain.

Executives

Pu Zhongjie	2201 Interest of corporation controlled by you
Hu Chaohong	2201 Interest of corporation controlled by you
Pu Jue	2201 Interest of corporation controlled by you
Hao Chunmei	2202 Interest of your spouse
Su Rongyu	2101 Beneficial owner
Miracogen Inc.	2201 Interest of corporation controlled by you
Miracogen Limited	2101 Beneficial owner
Cereblue Limited	2201 Interest of corporation controlled by you
Bei Jing Hou De Yi Min Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Hou De Yi Min Xin Xi Ke Ji You Xian Gong Si	2101 Beneficial owner
Le Pu Bei Jing Yi Liao Qi Xie Gu Fen You Xian Gong Si	2101 Beneficial owner
Lv Yuan Shang Hai Ke Ji You Xian Gong Si	2101 Beneficial owner

Lepu Biopharma Co Headlines

No Headlines